Mates Sharon - Insider Transactions
Insider Type
individual
Companies
1
Average
1,329,763
Total Txns
38
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 38 | -38 | 0.00 | 50,531,010.30 | -50,531,010.30 |
| Total: | 0 | 38 | 10 | 0.00 | 50,531,010.30 | -50,531,010.30 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
85.62 USD |
27,667 Sold |
2,368,909 USD |
04/12/2024 | 04/12/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
86.00 USD |
23,333 Sold |
2,006,750 USD |
04/12/2024 | 04/12/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
84.69 USD |
1,534 Sold |
129,914 USD |
04/12/2024 | 05/12/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
84.06 USD |
50,163 Sold |
4,216,928 USD |
04/12/2024 | 05/12/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
73.32 USD |
6,193 Sold |
454,091 USD |
29/08/2024 | 30/08/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
72.44 USD |
29,832 Sold |
2,161,114 USD |
29/08/2024 | 29/08/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
73.25 USD |
5,772 Sold |
422,771 USD |
29/08/2024 | 29/08/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
72.73 USD |
28,203 Sold |
2,051,261 USD |
29/08/2024 | 30/08/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
74.59 USD |
22,713 Sold |
1,694,229 USD |
26/08/2024 | 26/08/2024 |
| Intra-Cellular Therapies Inc. Common Stock US46116X1019 |
73.33 USD |
23,657 Sold |
1,734,865 USD |
26/08/2024 | 27/08/2024 |